Home /
Insights /
Will Life Sciences Companies Face More Scrutiny in 2018?

Will Life Sciences Companies Face More Scrutiny in 2018?

January 9, 2018

Law360

Partners John Bentivoglio and Jennifer Bragg look at key enforcement trends for life sciences companies from 2017 and discuss what to expect in the year ahead.

Stay Connected

@SkaddenArps

July 19 Counsel Austin Brown and Darren Welch take a look at educational income share agreements, an increasingly popular a… twitter.com/i/web/status/1…
July 18 The Preventing Adversaries Internationally from Disbursing Advertising Dollars Act was introduced in the Senate in… twitter.com/i/web/status/1…
July 18 PACs and other committees are reminded to update their FEC passwords to comply with changes to the agency's Electro… twitter.com/i/web/status/1…